GRINA

Chr 8

glutamate ionotropic receptor NMDA type subunit associated protein 1

Also known as: HNRGW, LFG1, NMDARA1, TMBIM3

The protein functions as a calcium channel and potential apoptotic regulator involved in endoplasmic reticulum calcium homeostasis and negative regulation of neuronal apoptosis. Mutations cause autosomal recessive developmental and epileptic encephalopathy with intellectual disability. The gene shows moderate constraint against loss-of-function variants (LOEUF 0.49), suggesting some intolerance to complete protein loss.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
9
Pubs (1 yr)
62
P/LP submissions
0%
P/LP missense
0.49
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryGRINA
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.22) despite low pLI — interpret in context.
📋
ClinVar Variants
61 unique Pathogenic / Likely Pathogenic· 58 VUS of 134 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.49LOEUF
pLI 0.442
Z-score 3.13
OE 0.22 (0.100.49)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.21Z-score
OE missense 0.76 (0.670.87)
153 obs / 201.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.22 (0.100.49)
00.351.4
Missense OE0.76 (0.670.87)
00.61.4
Synonymous OE1.27
01.21.6
LoF obs/exp: 4 / 18.6Missense obs/exp: 153 / 201.3Syn Z: -2.04
DN
0.77top 25%
GOF
0.79top 25%
LOF
0.3067th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

134 submitted variants in ClinVar

Classification Summary

Pathogenic56
Likely Pathogenic5
VUS58
Likely Benign2
56
Pathogenic
5
Likely Pathogenic
58
VUS
2
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
56
0
56
Likely Pathogenic
0
0
5
0
5
VUS
0
48
10
0
58
Likely Benign
0
2
0
0
2
Benign
0
0
0
0
0
Total050710121

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

GRINA · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →